Antiproliferative activity of the dietary isothiocyanate erucin, a bioactive compound from cruciferous vegetables, on human prostate cancer cells

Nutrition and Cancer

Volumn 65, Issue 1, 2013, Pages 132-138

  Melchini, Antonietta ^a,b   Traka, Maria H ^b   Catania, Stefania ^c   Miceli, Natalizia ^a   Taviano, Maria Fernanda ^a   Maimone, Patrizia ^a   Francisco, Marta ^d   Mithen, Richard F ^b   Costa, Chiara ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c UNIVERSITY OF MESSINA   (Italy)

^d MISIÓN BIOLÓGICA DE GALICIA CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; ERUCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SULFORAPHANE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MALE; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VEGETABLE;

ADENOCARCINOMA; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MALE; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SULFIDES; THIOCYANATES; VEGETABLES;

ANIMALIA; BRASSICA OLERACEA VAR. ITALICA;

EID: 84873726767     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.741747     Document Type: Article

References (34)

1. Ferlay J, Parkin DM, and Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46, 765-781, 2010.
2. Traka M, Gasper AV, Melchini A, Bacon JR, Needs PW, et al.: Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One 3, e2568, 2008
3. Traka MH, Spinks CA, Doleman JF, Melchini A, Ball RY, et al.: The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a PTEN null preclinical murine model of prostate cancer. Mol Cancer 13, 189, 2010.
4. Steinbrecher A, Nimptsch K, Hüsing A, Rohrmann S, and Linseisen J: Dietary glucosinolate intake and risk of prostate cancer in the EPIC-Heidelberg cohort study. Int J Cancer 125, 2179-2186, 2009.
5. Juge N, Mithen RF, and Traka M: Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64, 1105-1127, 2007.
6. Melchini A and Traka MH: Biological profile of erucin: a new promising anticancer agent from cruciferous vegetables. Toxins 2, 593-612, 2010.
7. Gmelin R and Schluter M: Isolation of 4-methylthiobutylglucosinolate (glucoerucin) from seeds of Eruca sativa Mill. Arch Pharm Ber Dtsch Pharm Ges 303, 330-334, 1970.
8. Clarke JD, Hsu A, Riedl K, Bella D, Schwartz SJ, et al.: Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol Res 64, 456-463, 2011.
9. Kassahun K, Davis M, Hu P, Martin B, and Baillie T: Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase I metabolites and glutathione conjugates. Chem Res Toxicol 10, 1228-1233, 1997.
10. Vermeulen M, van den Berg R, Freidig AP, van Bladeren PJ, and Vaes WH: Association between consumption of cruciferous vegetables and condiments and excretion in urine of isothiocyanate mercapturic acids. J Agric Food Chem 54, 5350-5358, 2006.
11. Melchini A, Costa C, Traka M, Miceli N, Mithen R, et al.: Erucin, a new promising cancer chemopreventive agent from rocket salads, shows anti-proliferative activity on human lung carcinoma A549 cells. Food Chem Toxicol 47, 1430-1436, 2009.
12. Hanlon N, Coldham N, Sauer MJ, and Ioannides C: Modulation of rat pulmonary carcinogen-metabolising enzyme systems by the isothiocyanates erucin and sulforaphane. Chem Biol Interact 177, 115-120, 2009.
13. Wang W, Wang S, Howie AF, Beckett GJ, Mithen R, et al.: Sulforaphane, erucin, and iberin up-regulate thioredoxin reductase 1 expression in human MCF-7 cells. J Agric Food Chem 53, 1417-1421, 2005.
14. Jakubikova J, Sedlak J, Mithen R, and Bao Y: Role of PI3K/AKT and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem Pharmacol 69, 1543-1552, 2005.
15. Fimognari C, Nusse M, Iori R, Cantelli-Forti G, and Hrelia P: The new isothiocyanate 4-(methylthio)butylisothiocyanate selectively affects cellcycle progression and apoptosis induction of human leukemia cells. Invest New Drugs 22, 119-129, 2004.
16. Lamy E, Schröder J, Paulus S, Brenk P, Stahl T, et al.: Antigenotoxic properties of Eruca sativa (rocket plant), erucin and erysolin in human hepatoma (Hep G2) cells towards benzo(a)pyrene and their mode of action. Food Chem Toxicol 46, 2415-2421, 2008.
17. Harris KE and Jeffery EH: Sulforaphane and erucin increase MRP1 and MRP2 in human carcinoma cell lines. J Nutr Biochem 19, 246-254, 2008.
18. Shukla S and Gupta S: Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 53, 18-32, 2005.
19. Nakamura Y: Chemoprevention by isothiocyanates: molecular basis of apoptosis induction. Forum Nutr 61, 170-181, 2009.
20. Wang LG and Chiao JW: Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation (review). Int J Oncol 37, 533-539, 2010.
21. Wang LG, Liu XM, Fang Y, Dai W, Chiao FB, et al.: De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Int J Oncol 33, 375-380, 2008.
22. Chambers KF, Bacon JR, Kemsley EK, Mills RD, Ball RY, et al.: Gene expression profile of primary prostate epithelial and stromal cells in response to sulforaphane or iberin exposure. Prostate 69, 1411-1421, 2009.
23. Traka MH, Chambers KF, Lund EK, Goodlad RA, Johnson IT, et al.: Involvement of KLF4 in sulforaphane- and iberin-mediated induction of p21 (waf1/cip1). Nutr Cancer 61, 137-145, 2009.
24. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, et al.: The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 275, 18391-18398, 2000.
25. Traka M, Gasper AV, Smith JA, Hawkey CJ, Bao Y, et al.: Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane. J Nutr 135, 1865-1872, 2005.
26. Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, et al.: The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther 8, 2496-2508, 2009.
27. Diener KR, Need EF, Buchanan G, and Hayball JD: TGF-beta signalling and immunity in prostate tumourigenesis. Expert Opin Ther Targets 14, 179-192, 2010.
28. Mebratu Y and Tesfaigzi Y: How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle 8, 1168-1175, 2009.
29. Ruscica M, Dozio E, Motta M, and Magni P: Modulatory actions of neuropeptide Y on prostate cancer growth: role of MAP kinase/ERK 1/2 activation. Adv Exp Med Biol 604, 96-100, 2007.
30. Moro L, Arbini AA, Marra E, and Greco M: Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. Int J Oncol 30, 217-224, 2007.
31. Yang MD, Lai KC, Lai TY, Hsu SC, Kuo CL, et al.: Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappa B signal pathways. Anticancer Res 30, 2135-2143, 2010.
32. Xu C, Yuan X, Pan Z, Shen G, Kim JH, et al.: Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol Cancer Ther 5, 1918-1926, 2006.
33. Xu C, Shen G, Yuan X, Kim JH, Gopalkrishnan A, et al.: ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 27, 437-445, 2006.
34. Lamy E and Mersch-Sundermann V: MTBITC mediates cell cycle arrest and apoptosis induction in human Hep G2 cells despite its rapid degradation kinetics in the in vitro model. Environ Mol Mutagen 50, 190-200, 2009.